Ascentage Pharma Group International
HKEX:6855

Watchlist Manager
Ascentage Pharma Group International Logo
Ascentage Pharma Group International
HKEX:6855
Watchlist
Price: 52.55 HKD 1.94% Market Closed
Market Cap: 19.6B HKD

Intrinsic Value

The intrinsic value of one Ascentage Pharma Group International stock under the Base Case scenario is 74.28 HKD. Compared to the current market price of 52.55 HKD, Ascentage Pharma Group International is Undervalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
74.28 HKD
Undervaluation 29%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ascentage Pharma Group International

What is Valuation History?
Ask AI Assistant
What other research platforms think about Ascentage Pharma Group International?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Ascentage Pharma Group International valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Ascentage Pharma Group International.

Explain Valuation
Compare Ascentage Pharma Group International to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Ascentage Pharma Group International?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ascentage Pharma Group International

Current Assets 1.9B
Cash & Short-Term Investments 1.7B
Receivables 78.4m
Other Current Assets 168.9m
Non-Current Assets 1.1B
Long-Term Investments 37.3m
PP&E 872m
Intangibles 95.7m
Other Non-Current Assets 132.4m
Current Liabilities 1.2B
Accounts Payable 118.7m
Short-Term Debt 442m
Other Current Liabilities 678.6m
Non-Current Liabilities 1.1B
Long-Term Debt 882.4m
Other Non-Current Liabilities 258.5m
Efficiency

Free Cash Flow Analysis
Ascentage Pharma Group International

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ascentage Pharma Group International

Revenue
390.6m CNY
Cost of Revenue
-35.7m CNY
Gross Profit
354.9m CNY
Operating Expenses
-1.5B CNY
Operating Income
-1.2B CNY
Other Expenses
-6.4m CNY
Net Income
-1.2B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Ascentage Pharma Group International's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Net Margin is Increasing
22/100
Profitability
Score

Ascentage Pharma Group International's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Ascentage Pharma Group International's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Long-Term Solvency
Average Altman Z-Score
39/100
Solvency
Score

Ascentage Pharma Group International's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Ascentage Pharma Group International

Wall Street analysts forecast Ascentage Pharma Group International stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ascentage Pharma Group International is 101.67 HKD with a low forecast of 89.89 HKD and a high forecast of 119.7 HKD.

Lowest
Price Target
89.89 HKD
71% Upside
Average
Price Target
101.67 HKD
93% Upside
Highest
Price Target
119.7 HKD
128% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Ascentage Pharma Group International
does not pay dividends
Shareholder Yield

Current shareholder yield for Ascentage Pharma Group International is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

News

Other Videos
What is the Intrinsic Value of one Ascentage Pharma Group International stock?

The intrinsic value of one Ascentage Pharma Group International stock under the Base Case scenario is 74.28 HKD.

Is Ascentage Pharma Group International stock undervalued or overvalued?

Compared to the current market price of 52.55 HKD, Ascentage Pharma Group International is Undervalued by 29%.

Back to Top